ABUS (GE & Siemens) fails to adequately screen the entire breast, missing the axilla. It is frequently painful and finds far fewer 4-7mm breast cancers. ABUS is unable to find cancer in women with implants and is not as effective for women with small breasts.
SonoCiné screens 100% of breast tissue, has no painful compression, and reliably finds 4-10mm breast cancers in women with all breast sizes and densities, as well as, breasts with implants.